Rules For Flu Pretepidēmij Measures

Original Language Title: Noteikumi par gripas pretepidēmijas pasākumiem

Read the untranslated law here:

Cabinet of Ministers Regulations No. 948 in the 2006 Riga, 21 November (pr. No 61 20. §) rules on influenza pretepidēmij measures Issued in accordance with the epidemiological safety law in the first part of article 14, paragraph 5 of rule 1 defines pretepidēmij activities carried out by the medical treatment person, if the patient has the flu or has a reasonable suspicion of being infected with the flu.
2. Influenza measures include: pretepidēmij 2.1. reporting of cases with influenza;
2.2. a case of the flu the epidemiological inquiry;
2.3. clinical sampling rules laid down in paragraph 4;
2.4. influenza monitoring (the systematic epidemiological data collection, compilation and analysis of acute upper respiratory infections (including cases of influenza and pneumonia) and viral spread of influenza circulation during the season – a period of current year 40 weeks to 20 next year for the week);
UR2.5.pas contributes to that particular area, place, or object under the mioloģisk situation of epid, including this provision in paragraph 5 specified cases.
3. If the person for treatment of influenza starpepidēmij has encountered professionally reasonable suspicion about the presence of the block with the flu (five or more epidemiologically linked cases of acute following the simpt tions: sudden onset of disease, rapid increases in body temperature above 38 ° C, aching muscles, headache, cough, pain in his neck), it shall, without delay, any time of the day by telephone reported to the State Agency "public health agency" (hereinafter referred to as the public health agency) branch.
4. the person provides clinical treatment material delivery of laboratory sampling and virological diagnosis of influenza and influenza virus circulating supervision in the following cases: professional a reasonable suspicion about the presence of the block with the flu;
4.2. acute upper respiratory infection in hospitalized patients progressing with complications;
4.3. flu progressing with the complications a person is vaccinated against the flu with the World Health Organization recommended les vaccines given the epidemic season;
4.4. the death occurred in a patient with acute upper respiratory infection symptoms;
4.5. a person with acute upper respiratory infection symptoms within seven days before illness visited bird flu affected countries (areas), avian influenza affected farm (farm) or otherwise been exposed to risk of being infected with bird flu.
5. The medical establishment is developing an action plan to work during the influenza epidemic and the influenza epidemic threat it is implemented (that plan may include existing authorities and pretepidēmisk mode of hygiene plan). The plan includes the following: 5.1. treatment of individual workers in flu prevention (vaccination of staff, specific influenza preparations and use of protective equipment);
5.2. the hospital's operating mode, including flu restrictive measures;
5.3. the flu patient treatment and care tactic;
5.4. the reserve medical personnel support and involvement of additional resources;
5.5. the hospital's bed pārprofilēšan a flu epidemic;
5.6. the hospital's staff training, what to do during a flu epidemic;
5.7. patients and their families in the education of influenza prevention.
6. The public health agency's branches: 6.1. determine the flu treatment involved in the monitoring authority (physicians), including primary health care clinics, hospital treatment, as well as educational institutions (influenza monitoring bodies involved in serving not less than 5-10% of the State population);
6.2. influenza monitoring informed the parties involved in the selection of data requirements and reporting procedures.
7. monitoring of flu treatment involved persons once a week this provision 2.4. the period referred to in the public health agency's branch provides data on cases with influenza (annex).
8. public health agency provides: clinical examination of samples 8.1 influenza virus and specific antibody detection;
8.2. influenza virus isolation in cell culture;
8.3. characterization of influenza virus isolates (tipēšan);
8.4. the transmission of influenza virus isolates to the regional World Health Organisation reference centre;
8.5. data analysis for the laboratory confirmed influenza and other virus-caused acute upper respiratory infections;
8.6. influenza monitoring data of the World Health Organization and the European Union of the influenza epidemiological surveillance bodies according to the European Centre for disease control and Prevention Center of the Latvian delegation circulating influenza viruses and resulting in acute upper respiratory infections;
8.7. influenza monitoring results, operational epidemiological analysis of data and information to the public.
Prime Minister a. Halloween Health Minister g. Smith Editorial Note: the entry into force of the provisions by 25 November 2006.
Annex to the Cabinet of Ministers on 21 November 2006 of Regulation No 544 flu monitoring indicators Health Minister g. Smith